GregoryAHaleMDCPE, FAAP, FACHE, CHCQM, CPHQ, CPPS, MBA

Pediatric Hematology & Oncology • Cincinnati, OH

Pediatric Anemia and Red Blood Cell Hematology, Pediatric Coagulation Disorder Hematology, Pediatric Solid Tumor Oncology, Clinical Pharmacology

Senior Medical Director Hematology, Oncology, Cellular Therapy

Join to view full profile

Dr. Hale is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hale's full profile

Already have an account?

Office
Medpace Way
Cincinnati, OH 45227
Phone+1 513-582-5595
Is this information wrong?

Summary

Dr. Gregory Hale is a pediatric hematologist/oncologist in Cincinnati, OH and is affiliated with multiple hospitals in the area, including AdventHealth Orlando and AdventHealth Tampa. He received his medical degree from Marshall University Joan C. Edwards School of Medicine and has been in practice 27 years. He specializes in pediatric anemia and red blood cell hematology, pediatric coagulation disorder hematology, pediatric solid tumor oncology, and clinical pharmacology and is experienced in pediatric bone marrow transplantation.

Education & Training

University of TennesseeFellowship, Pediatric Hematology/Oncology, 1993 - 1996
UPMC Children's Hospital of PittsburghResidency, Pediatrics, 1990 - 1993
Marshall University Joan C. Edwards School of MedicineClass of 1990
Marshall UniversityBS, Chemistry, Summa Cum Laude, 1983 - 1986

Certifications & Licensure

FL State Medical License 2008 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Castle Connelly Outstanding Physician Castle Connelly, 2016
Nominee, Physician of the Year Johns Hopkins Medicine, 2015
Good Catch Award All Children's Hospital, 2014
Distinguished Alumnus Award Marshall University, 2010
Best Doctors in America 2010
Marquis Who's-Who in America 2009
Top Doctors Tampa Bay Metro, 2009, 2013
Leading Health Professionals of the World 2008 in Pediatric Hematology Oncology International Biographical Center, 2008
Leading Health Professionals of the World 2007
Outstanding Physician Award St. Jude Children's Research Hospital, 2007
America's Top Oncologists Consumer Research Council of America, 2007
Best Abstracts Award for Clinical Research American Society of Blood and Marrow Transplantation (ASBMT), 2007
America's Top Physicians Consumer's Research Council of America, 2005
American Cancer Society Clinical Oncology Fellowship Award, 1994
Thomas G. Folsom Award Marshall University School of Medicine, 1990
Upjohn Achievement Award Marshall University School of Medicine, 1990
Bertha and Lake Polan Award Marshall University School of Medicine, 1990
Alpha Omega Alpha Marshall University School of Medicine, 1989
Year Two Achievement Award Marshall University School of Medicine, 1988
Year One Achievement Award Marshall University School of Medicine, 1987
Charles O. Reynolds Scholarship Marshall University School of Medicine, 1986
National Merit Scholar Marshall University, 1983
John Marshall Scholar Marshall University, 1983
Join now to see all

Clinical Trials

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Start of enrollment: 2001 Feb 01
Unknown status
Phase 3
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma Start of enrollment: 2004 Mar 15
Completed
Phase 3
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Start of enrollment: 2004 Sep 04
Completed
Phase 3
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 25
Recruiting
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Start of enrollment: 2004 Apr 01
Active, not recruiting
Phase 3
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma Start of enrollment: 2005 Nov 14
Completed
Phase 3
Stem Cell Transplantation for Patients With Hematologic Malignancies Start of enrollment: 2002 May 01
Completed
Phase 3
Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma Start of enrollment: 1998 Aug 01
Completed
Phase 1
Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission Start of enrollment: 2005 May 30
Completed
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer Start of enrollment: 2006 Feb 20
Completed
Phase 3
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor Start of enrollment: 2007 May 03
Completed
Phase 3
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant Start of enrollment: 2006 Apr 01
Completed
Phase 2
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Start of enrollment: 2006 Jun 01
Completed
Phase 2
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma Start of enrollment: 2007 Aug 06
Active, not recruiting
Phase 3
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Start of enrollment: 2006 Oct 30
Active, not recruiting
Phase 3
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Start of enrollment: 2006 Dec 26
Completed
Phase 3
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes Start of enrollment: 2007 Mar 01
Completed
Phase 3
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Start of enrollment: 2007 May 01
Completed
Phase 3
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor Start of enrollment: 2007 Feb 26
Active, not recruiting
Phase 3
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Start of enrollment: 2007 Mar 01
Completed
Phase 3
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission Start of enrollment: 2007 Mar 01
Completed
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Start of enrollment: 2007 Jan 22
Active, not recruiting
Phase 3
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia Start of enrollment: 2007 Jan 01
Completed
Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases Start of enrollment: 2007 Dec 31
Completed
Phase 3
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin Start of enrollment: 2007 May 01
Completed
Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia Start of enrollment: 2008 Jan 01
Completed
Phase 2
Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma Start of enrollment: 2008 Feb 04
Active, not recruiting
Phase 3
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2008 Jan 15
Active, not recruiting
Phase 3
Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System Start of enrollment: 2008 Dec 08
Active, not recruiting
Phase 3
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia Start of enrollment: 2008 Apr 01
Completed
Phase 2
Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission Start of enrollment: 1991 Mar 01
Completed
Phase 1
Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers Start of enrollment: 2008 Jun 02
Completed
International Pediatric Adrenocortical Tumor Registry Start of enrollment: 2001 Oct 01
Recruiting
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Start of enrollment: 2008 Jun 23
Completed
Phase 3
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
Recruiting
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
Recruiting
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2009 Jan 01
Completed
Phase 2
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia Start of enrollment: 2009 Mar 09
Completed
Phase 3
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Start of enrollment: 2009 Mar 01
Completed
Phase 2
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors Start of enrollment: 2008 Sep 01
Completed
Phase 1
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2006 Sep 25
Completed
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Tissue From Young Patients With Cancer Start of enrollment: 2007 Mar 05
Recruiting
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma Start of enrollment: 2006 Oct 23
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases Start of enrollment: 2001 Dec 01
Recruiting
Phase 1, Phase 2
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Study of Blood Samples From Newborns With Down Syndrome Start of enrollment: 2009 Feb 23
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma Start of enrollment: 2005 May 30
Completed
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma Start of enrollment: 2010 Jan 01
Completed
Phase 2
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia Start of enrollment: 2011 Feb 01
Completed
Phase 2
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients Start of enrollment: 2010 Jan 01
Completed
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma Start of enrollment: 2010 Oct 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors Start of enrollment: 2011 Feb 09
Completed
Phase 1, Phase 2
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Start of enrollment: 2011 Mar 01
Completed
Phase 3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2011 Jul 18
Completed
Phase 1
Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2011 Sep 01
Completed
Phase 2
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Start of enrollment: 2011 May 01
Completed
Not Applicable
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Start of enrollment: 2011 Sep 01
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor Start of enrollment: 2011 Aug 01
Completed
Phase 2
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Start of enrollment: 2012 Feb 21
Active, not recruiting
Phase 3
Metformin in Children With Relapsed or Refractory Solid Tumors Start of enrollment: 2012 Sep 24
Completed
Phase 1
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Start of enrollment: 2012 Jun 27
Active, not recruiting
Phase 2
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
A Safety Study of SGN-CD19A for Leukemia and Lymphoma Start of enrollment: 2013 Feb 01
Completed
Phase 1
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment Start of enrollment: 2014 Mar 05
Recruiting
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Start of enrollment: 2013 Jun 17
Active, not recruiting
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant Start of enrollment: 2013 Nov 04
Completed
Phase 3
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia Start of enrollment: 2013 Jun 24
Completed
Phase 2
Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer Start of enrollment: 2013 Oct 01
Withdrawn
Phase 2
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. Start of enrollment: 2013 Aug 20
Completed
Phase 2
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
Active, not recruiting
Phase 2
Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma Start of enrollment: 2013 Dec 24
Completed
Phase 2
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
Active, not recruiting
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

9 citations
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes
Betul Oran, Kwang Woo Ahn, Caitrin Fretham, Amer Beitinjaneh, Asad Bashey, Attaphol Pawarode, Baldeep Wirk, Bart L. Scott, Bipin N. Savani, Christopher Bredeson, Danie...> ;Transplantation and Cellular Therapy. 2021 Aug 14
1 citations
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with L...
Nelli Bejanyan, Mei-Jie Zhang, Khalid Bo-Subait, Claudio G. Brunstein, Hai-Lin Wang, Erica D. Warlick, Sergio Giralt, Taiga Nishihori, Rodrigo Martino, Jakob Passweg, ...> ;Transplantation and Cellular Therapy. 2021 Jan 1
9 citations
Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requireme...
Marcelo C Pasquini, Alok Srivastava, Syed Osman Ahmed, Mahmoud Aljurf, Yoshiko Atsuta, Carol Doleysh, Sebastian Galeano, Eliane Gluckman, Hildegard Greinix, Gregory Ha...> ;Hematology/oncology and Stem Cell Therapy. 2020 Sep 1
19 citations
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients
Bei Hu, Xiao Lin, Hans C. Lee, Xuelin Huang, Rebecca S. S. Tidwell, Kwang Woo Ahn, Zhen-Huan Hu, Elias Jabbour, Srdan Verstovsek, Farhad Ravandi, Guillermo Garcia-Mane...> ;Leukemia & Lymphoma. 2020 Jul 14
3 citations
Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors
Jack W. Hsu, Bronwen E. Shaw, Soyoung Kim, Brent R. Logan, Jennifer A. Sees, Dennis L. Confer, Michael A. Pulsipher, Nirali N. Shah, Galen E. Switzer, Muneer H. Abidi,...> ;Biology of Blood and Marrow Transplantation. 2020 Jun 1
10 citations
Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Tra...
David Buchbinder, Ruta Brazauskas, Khalid Bo-Subait, Karen K. Ballen, Susan K. Parsons, Tami John, Theresa Hahn, Akshay Sharma, Amir Steinberg, Anita D'Souza, Anita J....> ;Biology of Blood and Marrow Transplantation. 2020 Mar 1
3 citations
Comparison of melphalan- And busulfan-based myeloablative conditioning in children undergoing allogeneic transplantation for acute myeloid leukemia or myelodysplasia.
Benjamin Oshrine, Lauren K. Adams, Anh Thy H. Nguyen, Ernest K. Amankwah, David Shyr, Gregory A. Hale, Aleksandra Petrovic> ;Pediatric Transplantation. 2020 Feb 18
34 citations
Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic...
Christopher E. Dandoy, Soyoung Kim, Min Chen, Kwang Woo Ahn, Monica I. Ardura, Valerie I. Brown, Saurabh Chhabra, Miguel Angel Diaz, Christopher C. Dvorak, Nosha Farha...> ;JAMA Network Open. 2020 Jan 3
8 citations
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and ...
Marcelo C Pasquini, Alok Srivastava, Syed Osman Ahmed, Mahmoud Aljurf, Yoshiko Atsuta, Carol Doleysh, Sebastian Galeano, Eliane Gluckman, Hildegard Greinix, Gregory A ...> ;Biology of Blood and Marrow Transplantation. 2019 Dec 1
6 citations
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report
Haesook T. Kim, Kwang Woo Ahn, Zhen-Huan Hu, Matthew S. Davids, Virginia O. Volpe, Joseph H. Antin, Mohamed L. Sorror, Mazyar Shadman, Oliver W. Press, Joseph Pidala, ...> ;Clinical Cancer Research. 2019 Aug 15
11 citations
The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time
Nicole L. Prokopishyn, Brent R. Logan, Deidre M. Kiefer, Jennifer A. Sees, Pintip Chitphakdithai, Ibrahim Ahmed, Paolo Anderlini, Amer Beitinjaneh, Christopher Bredeso...> ;Biology of Blood and Marrow Transplantation. 2019 Jul 1
6 citations
Low-dose azacitidine for relapse prevention after allogeneic hematopoietic cell transplantation in children with myeloid malignancies.
Benjamin Oshrine, David C. Shyr, Gregory A. Hale, Aleksandra Petrovic> ;Pediatric Transplantation. 2019 Jun 1
6 citations
Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Biology of Blood and Marrow Transplantation. 2019 May 1
38 citations
Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and ...
Yoshihiro Inamoto, Nuria Valdés-Sanz, Yoko Ogawa, Monica Alves, Luigi Berchicci, John P. Galvin, Hildegard Greinix, Gregory A. Hale, Biljana Horn, Debra Lynch Kelly, H...> ;Bone Marrow Transplantation. 2019 May 1
11 citations
Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients
Sima T. Bhatt, Jeffrey J. Bednarski, Julia Berg, Kathryn Trinkaus, Lisa Murray, Robert J. Hayashi, Ginny Schulz, Monica Hente, Michael Grimley, Ka Wah Chan, Naynesh Ka...> ;Biology of Blood and Marrow Transplantation. 2019 Mar 1
2 citations
Allogeneic hematopoietic cell transplantation in chemotherapy-induced aplasia in children with high-risk acute myeloid leukemia or myelodysplasia.
Ashleigh Kussman, David C. Shyr, Gregory A. Hale, Benjamin Oshrine, Aleksandra Petrovic> ;Pediatric Blood & Cancer. 2019 Jan 1
17 citations
The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2.
Lisa G. Riley, Matthew M. Heeney, Joëlle Rudinger-Thirion, Magali Frugier, Dean R. Campagna, Ronghao Zhou, Gregory A. Hale, Lee Hilliard, Joel Kaplan, Janet L. Kwiatko...> ;Haematologica. 2018 Nov 30
24 citations
A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metform...
Matteo Trucco, Julio C. Barredo, John M. Goldberg, Gilles M. Leclerc, Gregory A. Hale, Jonathan Gill, Bhuvana A. Setty, Tiffany Smith, Richard Lush, Jae K. Lee, Damon ...> ;Pediatric Blood & Cancer. 2018 Sep 1
19 citations
Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial.
Shalini Shenoy, Mark C. Walters, Alex Ngwube, Sandeep Soni, David A. Jacobsohn, Sonali Chaudhury, Michael Grimley, Kawah Chan, Ann E. Haight, Kimberley A. Kasow, Suhag...> ;Biology of Blood and Marrow Transplantation. 2018 Jun 1
11 citations
Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants
Anita J. Kumar, Soyoung Kim, Michael T. Hemmer, Mukta Arora, Stephen R. Spellman, Joseph Pidala, Daniel R. Couriel, Amin M. Alousi, Mahmoud Aljurf, Jean-Yves Cahn, Mit...> ;Blood Advances. 2018 May 8
18 citations
NOURISH‐T: Targeting Caregivers to Improve Health Behaviors in Pediatric Cancer Survivors with Obesity
Marilyn Stern, Jennifer Bleck, Linda J. Ewing, Esther Davila, Courtney Lynn, Gregory A. Hale, Suzanne E. Mazzeo> ;Pediatric Blood & Cancer. 2018 May 1
2 citations
Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis
William A. Wood, Ruta Brazauskas, Zhen-Huan Hu, Hisham Abdel-Azim, Ibrahim Ahmed, Mahmoud Aljurf, Sherif M. Badawy, Amer Beitinjaneh, Biju George, David Buchbinder, Ja...> ;Biology of Blood and Marrow Transplantation. 2018 Sep 1
5 citations
Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34 + Yields Are Less
David F. Stroncek, Bronwen E. Shaw, Brent R. Logan, Deidre M. Kiefer, Bipin N. Savani, Paolo Anderlini, Christopher Bredeson, Peiman Hematti, Siddhartha Ganguly, Migue...> ;Biology of Blood and Marrow Transplantation. 2018 Jan 1
13 citations
Outcomes following autologous hematopoietic stem cell transplant for patients with relapsed Wilms' tumor: A CIBMTR retrospective analysis
Marcio H. Malogolowkin, Michael T. Hemmer, Jennifer Le-Rademacher, Gregory A. Hale, Parinda A. Mehta, Angela R. Smith, Carrie L. Kitko, Allistair Abraham, Hisham Abdel...> ;Bone Marrow Transplantation. 2017 Sep 4
12 citations
Personalized Prognostic Risk Score for Long-Term Survival for Children with Acute Leukemia after Allogeneic Transplantation.
Menachem Bitan, Kwang Woo Ahn, Heather R. Millard, Michael A. Pulsipher, Hisham Abdel-Azim, Jeffery J. Auletta, Valerie I. Brown, Ka Wah Chan, Miguel Angel Diaz, Andre...> ;Biology of Blood and Marrow Transplantation. 2017 Sep 1
Join now to see all

Journal Articles

The Phenotypic Spectrum of Germline YARS2 Variants: From Isolated Sideroblastic Anemia to Mitochondrial Myopathy, Lactic Acidosis and Sideroblastic Anemia 2
Matthew M Heeney, Gregory A Hale, David P Steensma, Mark D Fleming, Colin A Sieff, Lee M Hilliard, Sylvia S Bottomley, Janet L Kwiatkowski, Haematologica
Race and Ethnicity Influences Collection of G-CSF Mobilized Peripheral Blood Progenitor Cells from Unrelated Donors, a CIBMTR Analysis
Hsu JW, Wingard JR, Logan BR, Chhitphakdithai P, Akpek G, Anderlini P, Artz AS, Bredeson C, Goldtein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV..., Biol Blood Marrow Transplant, 1/1/2015
Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era
Majhail NS, Chitphakdithai P, Logan B, King B, Devine S, Rossman SN, Hale G, Hartzman RJ, Karanes C, Laport GG, Nemecek E, Snyder EL, Switzer GE, Miller J, Navarro W, ..., Biol Blood Marrow Transplant, 1/1/2015
Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan or Tota...
Copelan EA, Avalos B, Ahn KW, Zhu X, Gale RP, Grunwald MR, Hamadani M, Hamilton BK, Hale GA, Marks DI, Waller EK, Savani BN, Costa LJ, Ramanathan M, Cahn J, Khoury HJ,..., Biol Blood Marrow Transplant, 1/1/2015
Design and Rational for NOURISH-T: A Randomized Control Trial Targeting Parents of Overweight Children with Cancer Transitioning off Treatment
Stern M, Ewing L, Davila E, Thomson AL, Hale G, Mazzeo S, Contemp Clin Trials, 1/1/2015
Using Fludarabine to Reduce Exposure to Alkylating Agents in Children with Sickle Cell Disease Receiving Busulfan, Cyclophosphamide and Anti-thymocyte Globulin Transpl...
Horan JT, Haight A, Dioguardi JL, Brown C, Grizzle A, Shelman C, Kanter J, Hale G, Nieder M, Benton M, Kasow KA, Abraham A, Chiang KY, Biol Blood Marrow Transplant, 1/1/2015
New Cancers after Autotransplantations for Multiple Myeloma
Mahindra A. Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, Marks D..., New Cancers after Autotransplantations for Multiple Myeloma, 1/1/2015
A Novel Reduced Intensity Conditioning Regimen for Unrelated Umbilical Cord Blood Transplantation in Children with Non-malignant Diseases
Parikh SH, Mendizabal A, Benjamin CL, Komanduri KV, AAntony J, Petrovic A, Hale GA, Driscoll TA, Martin PL, Page K, Flickinger K, Moffet J, Niedzwiecki D, Kurtzberg J,..., Biol Blood Marrow Transplant, 1/1/2014
Avascular Necrosis of Bone following Allogeneic Hematopoietic Cell Transplantation in Children and Adolescents
Li X, Brazauskas R, Wang Z, Al-Seraihy A, Baker KS, Cahn JY, Frangoul HA, Gajewski JL, Hale GA, Hsu JW, Kamble RT, Lazarus HM, Marks DI, Maziarz RT, Savani BN, Shah AJ..., Biol Blood Marrow Transplant, 1/1/2014
Outcomes of Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma
Wirk B, Fenske TS, Hamadani M, Zhang MJ, Hu ZH, Akpek G, Aljurf MD, Armand P, Ayala E, Bachanova V, Bolwell B, Cairo MS, Cashen A, Chen YB, Costa LJ, Farhan S, Freytes..., Biol Blood Marrow Transplant, 1/1/2014
Outcomes of HLA Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocyteic Leukemia: Myeloablative Vs Reduced-intensity Condition Regimens
Sobecks RM, Leis, JF, Gale RP, Ahn KW, Zhu X, Sabloff M, de Lima M, Brown JR, Inamoto Y, Hale GA, Aljurf MD, Kamble RT, Hsu JW, Pavletic SZ, Wirk B, Seftel MD, Lewis ..., Biol Blood Marrow Transplant, 1/1/2014
Risk Associations between HLA-DPB1 T-cell Epitope Matching and Outcome of Unrelated Hematopoietic Cell Transplantation Are Independent of HLA-DPB1
Fleischhauer K, Fernandez-Vina MA, Wang T, Haagenson M, Battiwalla M, Baxter-Lowe LA, Ciceri F, Dehn J, Gajewski J, Hale GA, Heemskerk MB, Marino SR, McCarthy PL, Mikl..., Bone Marrow Transplant, 1/1/2014
Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced Intensity Conditioning
Ringden O, Brazauskas R, Wang Z, Ahmed I, Atsuta Y, Buchbinder D, Burns LJ, Cahn JY, Duncan C, Hale GA, Halter J, Hayashi RJ, Hsu JW, Jacobsohn DA, Kamble RT, Kamani N..., Biol Blood Marrow Transplant, 1/1/2014
Allogeneic Hematopoietic Cell Transplantation for Mycosis Fungoides and Sezary Syndrome
Lechowicz MJH, Lazarus HM, Carreras J, Laport GG, Cutler CS, Wiernik PH, Hale GA, Maharaj D, Gale RP, Rowlings PA, Freytes CO, Miller AM, Vose JM, Maziarz RT, Montoto ..., Bone Marrow Transplant, 1/1/2014
A Pharmacokinetic study of intravenous asparaginase Erwinia chrysanthemi following allergy to E coli-derived asparaginase in children and adolescents with acute lymph...
Vrooman LM, Kirov II, Dreyer ZE, Kelly M, Hijiya N, Brown P, Drachtman RA, Messinger YH, Ritchey AK, Hale GA, Maloney K, Lu Y, Plourde PV, Silverman LB, Blood, 1/1/2014
Standards for Pediatric Cancer Centers
Section on Hematology/Oncology (Hale GA)., Pediatrics, 1/1/2014
Second Malignancies after Autologous Hematopoietic Cell Transplantation in Children
Danner-Koptik KE, Majhail NS, Brazauskas R, Wang Z, Buchbinder D, Cahn JY, Dilley KJ, Frangoul HA, Gross TG, Hale GA, Hayashi RJ, Hijiya N, Kamble RT, Lazarus HM, Ma..., Bone Marrow Transplant, 1/1/2013
Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-unresponsive Mantle Cell Lymphoma: A Cohort Analysis from the CIBMTR
Hamadani M, Saber W, Ahn KW, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PN, Hsu JW, Inwards DJ, Kamble RT, Klein A, Maharaj D, Marks DI, Rizzier..., Biol Blood Marrow Transplant, 1/1/2013
Impact of Pretransplantation Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-unresponsive Diffuse Large B Cell Lymphoma and Grade III ...
Hamadani M, Saber W, Ahn KW, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PM, Hsu JW, Inwards DJ, Kamlbe RT, Klein A, Maharaj D, Marks DI, Rizzier..., Biol Blood Marrow Transplant, 1/1/2013
Birth Order and Transplant Outcome in HLA-identical Sibling Stem Cell Transplantation-an Analysis on Behalf of the Center for International Blood and Marrow Transplant...
Dobbelstein C, Ahn KW, Haagenson M, Hale GA, van Rood JJ, Miklos K, Waller EK, Spellman SR, Fernandez-Vina M, Genser A, Aljurf M, Bornhaeuser M, Gupta V, Marino S, Pol..., Biol Blood Marrow Transplant, 1/1/2013
Physician Perdceptions and Practice Patterns regarding Fertility Preservation in Hematopoietic Cell Transplant Recipients
Loren AW, Brazauskas R, Chow EJ, Gilleece M, Halter J, Jacobsohn DA, Joshi S, Pidala J, Quinn GP, Wang Z, Apperley JF, Burns LJ, Hale GA, Hayes-Lattin BM, Kamble R, La..., Bone Marrow Transplant, 1/1/2013
Allogeneic Hematopoietic Cell Transplantation for Fanconi Anemia in Patients with Pretransplantation Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leuk...
Ayaas M, Saber W, Davies SM, Harris RE, Hale GA, Socie G, Lerademacher J, Thakar M, Deeg HJ, Al-Seraihy A, Battiwalla M, Camitta BM, Olsson R, Bajwa RS, Bonfim CM, Pas..., J Clin Oncol, 1/1/2013
Unrelated Donor Allogeneic Transplantation after Failure of Autologous Transplantation for Acute Myeloid Leukemia: A Study from the CIBMTR
Foran JM, Pavletic SZ, Logan BR, Agovi-Johnson MA, Perez WS, Bolwell BJ, Bornhauser M, Bredeson CN, Cairo MS, Camitta BM, Copelan EA, Dehn J, Gale RP, Beorge B, Gupta ..., Biol Blood Marrow Transplant, 1/1/2013
Trends in Utilization and Survival after Autologous Hematopoietic Cell Transplantation in North America from 1995 to 2005: Significant Improvement in Survival for Lymp...
McCarthy PL, Hahn T, Hassebroek A, Bredeson C, Gajewski J, Hale GA, Isola L, Lazarus HM, Lee SJ, Lemaistre CF, Loberiza F, Maziarz RT, Rizzo DJ, Joffe S, Parsons S, Ma..., Biol Blood Marrow Transplant, 1/1/2013
Treatment of Epstein Barr Virus-induced Haemophagocytic Lymphohistiocytosis with Rituximab-containing Chemo-immunotherapeutic Regimens
Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, Nichols KE, for the EBV-HLH Rituximab Study Group (Hale GA)., Br J Haematol, 1/1/2013
Join now to see all

Books/Book Chapters

Hematopoietic Stem Cell Transplantation: A Handbook for Clinicians
Chapter: Pediatric Aspects of Transplantation
KA Kasow, GA HaleEditors: John Wingard, Dennis Gastineau, Helen Leather, Edwards Snyder, Zbigniew Szczepiorkowski.AABB2009
Advances in Patient Safety: New Direction and Alternative Approaches (vol. 2: Culture and Redesign).
Chapter: Analysis of Patient Safety: Converting Complex Pediatric Chemotherapy Ordering Processes from Paper to Electronic Systems
Baker DK, Hoffman JM, Hale GA, Spunt SL, Sanderlin D, Rodman J, Shenep JLEditors: Henriksen K, Battles, JB, Keyes MA, Grady ML.Agency for Healthcare Research and Quality, Rockville MD2008
Encyclopedia of Cancer and Society
Chapter: Overview of Hematopoietic Stem Cell Transplantation
KA Kasow, GA HaleEditors: J. Geoffrey Golson, Graham A. Colditz.SAGE Publications, Inc., Thousand Oaks, CA2007
Nutritional Support
Chapter: Supportive Care of Children with Cancer
N Sacks, K Ringwald-Smith, G HaleEditors: Arnold J. Altman.The Johns Hopkins University PressEdition 3rd,2004
Clinical Bone Marrow and Stem Cell Transplantation
Chapter: Allogeneic Hematopoietic Stem Cell Transplant for the Non-Hodgkin's Lymphomas and Hodgkin's Disease
GA Hale, GL Phillips, DE ReeceEditors: Atkinson, Fibbe, Champlin, Ljungman, Ritz, Brenner.Cambridge University PressEdition 3rd,2002
Join now to see all

Lectures

Facilitator, Lunch with the Specialists: Roundtable Discussions
All Children's Hospital, Sarasota, FL - 1/1/2011
Foundation in Bone Marrow Transplantation: Autologous Hematopoietic Stem Cell Transplantation
St. Jude Children's Research Hospital, Memphis, TN - 1/1/2005
Foundations in Bone Marrow Transplantation: Engraftment Syndrome
St. Jude Children's Research Hospital, Memphis, TN - 1/1/2005
Foundation for the Accreditation of Cellular Therapies
St. Jude Children's Research Hospital, Memphis, TN - 1/1/2002
Keynote Address, Frontiers in Hematopoietic Stem Cell Transplantation
Kennesaw University, Kennesaw, GA - 1/1/2002
Autologous Hematopoietic Stem Cell Transplantation
St. Jude Children's Research Hospital, Memphis, TN - 1/1/2001
Tidbits in Pediatric Hematology-Oncology
Department of Pediatrics, University of Kentucky - 1/1/1997
Stem Cell Transplantation
1/1/1997
Donor Leukocyte Infusions
St. Jude Children's Research Hospital, Memphis, TN - 1/1/1995
Adoptive Cellular Therapy in Allogeneic Bone Marrow Transplantation
Hematology-Oncology Grand Rounds - 1/1/1995
Long-term Side Effects of Therapy
University of Kentuck - 1/28/1997
Bone Marrow Transplant Update
University of Kentuck - 1/28/1997
Evaluation of Pediatric Anemia
University of Kentucky - 1/14/1997
Autologous Conditioning Regimens
St. Jude Children's Research Hospital, Memphis, TN - 1/4./2000
Stem Cell Transplantation for Children with Hematologic Malignancies
Beirut, Lebanon - 1/28/2000
Stem Cell Transplantation for Pediatric Solid Tumors
Beirut, Lebanon - 1/28/2000
Transplant Research Overview
St. Jude Children's Research Hospital, Memphis TN - 1/8./2001
Solid Tumors Treated via Transplantation
St. Jude Children's Research Hospital, Memphis, TN - 1/11/2001
Autologous Conditioning Regimens, Foundations in Pediatric Hematopoietic Stem Cell Transplantation
St. Jude Children's Research Hospital, Memphis, TN - 1/25/2001
Update of Pediatric Hematopoietic Stem Cell Transplantation
Marshall University School of Medicine, Huntington, WV - 1/28/2001
Memphis Health Information Management Association-Coding Roundtable
St. Jude Children's Research Hospital, Memphis, TN - 1/24/2002
Autologous Hematopoietic Stem Cell Transplantation for Pediatric Solid Tumors
St. Jude Children's Research Hospital, Memphis, TN - 1/18/2002
Foundations in Bone Marrow Transplantation: Autologous Transplantation for Children
St. Jude Children's Research Hospital, Memphis, TN - 1/22/2003
Foundations in Hematopoietic Stem Cell Transplantation
St. Jude Children's Research Hospital, Memphis, TN - 1/7./2003
Advances in Bone Marrow Transplant
St. Jude Children's Research Hospital, Memphis, TN - 1/24/2003
Join now to see all

Other

ABO Incompatibilities after Hematopoietic Stem Cell Ransplantation
Hale GA, Kentucky Association of Blood Banks
1/1/2006
Ask the Expert: Uses of Cord Blood Stem Cells
Hale G, McCumbee K, Scientific American Web Page
1/1/1997